美敦力公司宣布，其Stealth Axis™手术系统已获得美国食品药品监督管理局（FDA）的上市许可。该系统是脊柱外科领域首个集成了术前规划、术中导航和机器人辅助操作的一体化平台，标志着脊柱手术技术迈向全新阶段。
该平台通过将三维规划软件、实时导航系统与机器人器械控制相结合，能够帮助外科医生更精准地定位手术路径，提升植入物放置的准确性。临床数据显示，该技术可显著缩短手术时间，减少术中辐射暴露，并为复杂脊柱病例提供个性化手术方案。
此次获批进一步巩固了美敦力在智能外科领域的领先地位。公司表示，该平台将逐步在全球范围内推广，旨在通过数字化技术推动脊柱手术的标准化与精准化发展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.